These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 593431)

  • 1. Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain.
    Nielsen M; Braestrup C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):93-9. PubMed ID: 593431
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.
    Nielsen M; Braestrup C
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Oct; 300(1):87-92. PubMed ID: 593430
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histochemical study of the effect of drugs on the uptake of alpha-methylnoradrenaline by noradrenaline and dopamine containing neurones in rats treated with reserpine].
    Lorez HP
    Z Gesamte Exp Med Einschl Exp Chir; 1969; 151(3):241-60. PubMed ID: 5358460
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.
    Carlsson A; Fuxe K; Hamberger B; Lindqvist M
    Acta Physiol Scand; 1966; 67(3):481-97. PubMed ID: 5967609
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine.
    Carlsson A; Corrodi H; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1969 Mar; 5(4):367-73. PubMed ID: 5786360
    [No Abstract]   [Full Text] [Related]  

  • 6. Norepinephrine metabolism and drugs used in the affective disorders: a possible mechanism of action.
    Schildkraut JJ; Schanberg SM; Breese GR; Kopin IJ
    Am J Psychiatry; 1967 Nov; 124(5):600-8. PubMed ID: 4383104
    [No Abstract]   [Full Text] [Related]  

  • 7. Storage and synthesis of norepinephrine in the reserpine-treated rat brain.
    Glowinski J; Iversen LL; Axelrod J
    J Pharmacol Exp Ther; 1966 Mar; 151(3):385-99. PubMed ID: 4380046
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced metabolism and turnover rates of rat brain dopamine, norepinephrine and serotonin by chronic desipramine and zimelidine treatments.
    Karoum F; Korpi ER; Linnoila M; Chuang LW; Wyatt RJ
    Eur J Pharmacol; 1984 Apr; 100(2):137-44. PubMed ID: 6234178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of morphine and other centrally acting drugs on 3,4-dihydroxyphenylethylene glycol sulfate (DOPEG-SO4) in rat brain.
    Huff JW; Reigle TG
    Life Sci; 1980 Oct; 27(16):1483-8. PubMed ID: 7442455
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
    Carlsson A; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 Dec; 2(3):196-201. PubMed ID: 5590343
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain.
    Vosmer G; DeMet EM; Halaris AE
    Biochem Pharmacol; 1980 Oct; 29(19):2557-62. PubMed ID: 7426062
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification by desipramine (DMI) of the availability of norepinephrine released by reserpine in the hypothalamus of the rat in vivo.
    Sulser F; Owens ML; Strada SJ; Dingell JV
    J Pharmacol Exp Ther; 1969 Aug; 168(2):272-82. PubMed ID: 5803311
    [No Abstract]   [Full Text] [Related]  

  • 13. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of chronic apomorphine on the development of denervation supersensitivity.
    Robin M; Forler C; Palfreyman MG
    Pharmacol Biochem Behav; 1985 Apr; 22(4):547-51. PubMed ID: 3921992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of L-tyrosine on brain monoamines in rats given intravenous amphetamine.
    Smith DG; Geis LS; Lyness WH
    Subst Alcohol Actions Misuse; 1984-1985; 5(6):293-8. PubMed ID: 6085821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs.
    Aghajanian GK; Bloom FE
    J Pharmacol Exp Ther; 1967 Jun; 156(3):407-16. PubMed ID: 6027453
    [No Abstract]   [Full Text] [Related]  

  • 18. Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.
    Eisenhofer G; Ropchak TG; Stull RW; Goldstein DS; Keiser HR; Kopin IJ
    J Pharmacol Exp Ther; 1987 May; 241(2):547-53. PubMed ID: 3572811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of dopamine release by in vivo microdialysis in the nucleus accumbens of rats following acute and chronic administration of desipramine.
    See RE; Adams-Curtis L; Chapman MA
    Ann N Y Acad Sci; 1992 Jun; 654():522-4. PubMed ID: 1378710
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo studies on central noradrenergic synaptic mechanisms after acute and chronic antidepressant drug treatment: biochemical and behavioral comparison.
    Racagni G; Mocchetti I; Renna G; Cuomo V
    J Pharmacol Exp Ther; 1982 Oct; 223(1):227-34. PubMed ID: 7120121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.